Register Cart 0

Generic placeholder image

Current Medicinal Chemistry - Central Nervous System Agents

Editor-in-Chief

ISSN (Print): 1568-0150
ISSN (Online): 1875-6158

Back Subscribe

Subject Index to Volume 3

Author(s): Bentham Science Publishers

Volume 4, Issue 1, 2004

Page: [73 - 76] Pages: 4

DOI: 10.2174/1568015043477612

Price: $65

Abstract

« Previous

Rights & Permissions Print Cite

Article Metrics

9

Related Articles

Effect of Polyherbal Drug Majun Falasfa on the Transgenic Drosophila Model of Parkinson’s Disease
Current Traditional Medicine

Meet Our Associate Editorial Board Member
Current Psychopharmacology

Review of Recent Patents on Wearable Movement Sensors
Recent Patents on Biomedical Engineering (Discontinued)

Inhibitory Role of Resveratrol in the Development of Profibrogenesis and Fibrosis Mechanisms
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued)

Data Visualization and Feature Selection Methods in Gel-based Proteomics
Current Protein & Peptide Science

Combined Fine-Motor Tests and Self-Assessments for Remote Detection of Motor Fluctuations
Recent Patents on Biomedical Engineering (Discontinued)

Partial Dopamine Agonists and Dopaminergic Stabilizers, in the Treatment of Psychosis
Current Drug Targets - CNS & Neurological Disorders

Advantages of Structure-Based Drug Design Approaches in Neurological Disorders
Current Neuropharmacology

The Use of Stem Cells in Regenerative Medicine for Parkinson’s and Huntington’s Diseases
Current Medicinal Chemistry

Leukopenia Associated with Risperidone Treatment
Current Drug Safety

Glutamate Receptors as Therapeutic Targets for Parkinsons Disease
CNS & Neurological Disorders - Drug Targets

An Update on Human Stem Cell-Based Therapy in Parkinson's Disease
Current Stem Cell Research & Therapy

The Role of Tau Phosphorylation in the Pathogenesis of Alzheimers Disease
Current Alzheimer Research

Pharmacogenetic Studies of Psychotropic Drug-Induced Adverse Effects
Current Pharmacogenomics

Revisiting the Medical Management of Parkinson’s Disease: Levodopa versus Dopamine Agonist
Current Neuropharmacology

A Review on Emerging Drug Targets in Treatment of Schizophrenia
Current Drug Targets

Biomarkers of Chronic Kidney Disease - Mineral and Bone Disorder (CKD-MBD), A Review of Published Patents and Patent Applications
Recent Patents on Biomarkers

N-Methyl D-Aspartate (NMDA) Receptor Antagonists and Memantine Treatment for Alzheimer’s Disease, Vascular Dementia and Parkinson’s Disease
Current Alzheimer Research

The Endocannabinoid System in Ageing: A New Target for Drug Development
Current Drug Targets

Structural Properties of the NMDA Receptor and the Design of Neuroprotective Therapies
Mini-Reviews in Medicinal Chemistry

© 2024 Bentham Science Publishers | Privacy Policy